Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Colorectal Neoplasms 105Carcinoma, Hepatocellular 34Gastrointestinal Stromal Tumors 17Colonic Neoplasms 14Rectal Neoplasms 12Neoplasm Metastasis 12Liver Neoplasms 8Stomach Neoplasms 5Cholangiocarcinoma 5Pancreatic Neoplasms 4Esophageal Neoplasms 4Sarcoma 3Parkinson Disease 4, Autosomal Dominant Lewy Body 3Colorectal Cancer Metastatic 3Carcinoma, Renal Cell 3Advanced Colorectal Cancer 3Squamous Cell Carcinoma of Head and Neck 2Small Cell Lung Carcinoma 2Neoplasms 2Mesothelioma, Malignant 2Melanoma 2Lung Neoplasms 2Glioblastoma 2Gastrointestinal Neoplasms 2Gallbladder Neoplasms 2Fatigue 2Esophageal Squamous Cell Carcinoma 2Colorectal Cancer Liver Metastases 2Carcinoma, Transitional Cell 2Carcinoma, Non-Small-Cell Lung 2

Interventions

X-Rays 7Phantoms, Imaging 7Specimen Handling 6Magnetic Resonance Spectroscopy 6Nuclear Medicine Department, Hospital 5Filgrastim 4Cyclophosphamide 4Carboplatin 4Biopsy 4Thiotepa 3Temozolomide 3Mesna 3Melphalan 3Ifosfamide 3Granulocyte Colony-Stimulating Factor 3Busulfan 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2palbociclib 2olaparib 2larotrectinib 2ivosidenib 2fludarabine 2erdafitinib 2ensartinib 2Vemurafenib 2Topotecan 2Stem Cell Transplantation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Wilms Tumor × regorafenib × Gastrointestinal × Clear all
NCT02085148 2024-04-22

A Phase I Dose Finding Study in Children With Solid Tumors Recurrent or Refractory to Standard Therapy

Bayer

Phase 1 Completed
62 enrolled
CNSGastrointestinalGenitourinarySarcoma

Neoplasms, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡